THURSDAY, Dec. 8, 2022 (HealthDay News) — A relatively new drug is boosting survival rates for women with a specific type of advanced breast cancer who haven’t responded to other treatments, according to a pair of clinical trials. The targeted antibody drug — trastuzumab deruxtecan (T-DXd, sold under the brandContinue Reading
THURSDAY, Dec. 8, 2022 (HealthDay News) – Lasik eye surgery is a common vision-correcting procedure that many Americans view as safe and effective, but the U.S. Food and Drug Administration has now drafted guidance that warns of potential complications. Although many patients are happy with the results after surgery, theContinue Reading
TUESDAY, Dec. 6, 2022 (HealthDay News) — A small toilet-based sound sensor that can tell the difference between peeing, pooping and diarrhea may one day help prevent cholera outbreaks. “The hope is that this sensor, which is small in footprint and noninvasive in approach, could be deployed to areas whereContinue Reading
FRIDAY, Dec. 2, 2022 (HealthDay News) — It’s thought that for an HIV vaccine to be widely effective, it will have to spur the body to make special antibodies that can neutralize a broad range of HIV strains. Now scientists say they have taken an essential step in that direction.Continue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — Black adults who undergo a common procedure to open up clogged arteries are readmitted to the hospital more often than their white peers. They’re also more likely to die in the years after treatment, a new study finds. Researchers looked at how patientsContinue Reading
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain. In the eagerly awaited trial findings, published Tuesday in the New EnglandContinue Reading
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety. A 65-year-old woman with early-stage Alzheimer’s recently died from a massive brain bleed that some researchers link to lecanemab, anContinue Reading
MONDAY, Nov. 28, 2022 (HealthDay News) — Before Andrea Acerra, 45, had a hysterectomy due to heavy periods in November, she received an iron infusion to boost her red blood cell count and stave off the need for a transfusion. “I was just worried about side effects from the iron,Continue Reading
TUESDAY, Nov. 22, 2022 (HealthDay News) — Researchers have found a way to safely deliver a steady supply of chemotherapy directly to brain tumors — in what they hope will be an important advance for patients with currently incurable cancers. The treatment involves an implantable pump system that supplies aContinue Reading
TUESDAY, Nov. 22, 2022 (HealthDay News) — Annual lung cancer screening for heavy smokers can provide a big boost in lung cancer survival over the long term, a new study shows. When low-dose CT screening identifies early-stage lung cancer, patients have an 80% chance of surviving 20 years, researchers found.Continue Reading